Achieve Life Sciences Inc. (ACHV) - Rentabilitas reged

ACHV (Achieve Life Sciences Inc.) - tandha merek perusahaan

Geopolitical tensions and sanctions are hindering global clinical trials, as evidenced by the quarterly gross margin, where the figure reached 0.00. Meanwhile, demand for addiction therapy remains stable and is not subject to seasonality. The immense potential for combating vaping in the US will provide Achieve Life Sciences (ACHV) with powerful distribution channels for its innovative plant-based drug.

Tingkat bathi miturut bathi reged: achievelifesciences.com (ACHV) kanggo 04.07.2022 - 10.11.2026

Rincian metrik keuangan lan pasar achievelifesciences.com (ACHV)

- nilai saham lan prakiraan konsensus rega:
Produk dadi Achieve Life Sciences

Gross margin stability makes Achieve Life Sciences (ACHV) an attractive target for institutional investors seeking defensive assets during periods of macroeconomic turbulence. Analyzing the gross profitability chart, which reflects the profit share after deducting direct production costs, confirms the resilience of the company's cash flow, driven by the specifics of the regulated market and consistent demand for its products.